Pavonine Co., Ltd. (KOSDAQ:177830)
2,290.00
-20.00 (-0.87%)
At close: Aug 24, 2026
Pavonine Market Cap
Pavonine has a market cap or net worth of 21.43 billion as of August 24, 2026. Its market cap has decreased by -35.21% in one year.
Market Cap
21.43B
Enterprise Value
78.12B
Revenue
129.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,290.00
ChartMarket Cap Chart
Since August 4, 2014, Pavonine's market cap has decreased from 49.00B to 21.43B, a decrease of -56.25%. That is a compound annual growth rate of -6.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 21.43B | -34.76% |
| Dec 30, 2025 | 32.85B | -6.55% |
| Dec 30, 2024 | 35.16B | -19.11% |
| Dec 28, 2023 | 43.46B | -7.81% |
| Dec 29, 2022 | 47.14B | -24.27% |
| Dec 30, 2021 | 62.25B | -8.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ASTORY Co.,Ltd | 21.63B |
| Sejin T.S Co.,Ltd | 21.57B |
| Ocean In W | 21.49B |
| Ubion Co.Ltd. | 21.49B |
| ELP Corporation | 21.42B |
| Paru Co., Ltd | 21.40B |
| DT&CRO CO. | 21.34B |
| Xcell Therapeutics | 21.29B |